Last reviewed · How we verify

BENZHYDROCODONE — Competitive Intelligence Brief

BENZHYDROCODONE (BENZHYDROCODONE) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Opioid analgesic combination; full mu-opioid agonist with non-opioid analgesic. Area: Metabolic.

marketed Opioid analgesic combination; full mu-opioid agonist with non-opioid analgesic Mu-opioid receptors (primary); delta and kappa opioid receptors (secondary); central nervous system pain pathways Metabolic Small molecule Live · refreshed every 30 min

Target snapshot

BENZHYDROCODONE (BENZHYDROCODONE). Benzhydrocodone is a hydrocodone prodrug providing mu-opioid receptor agonism combined with acetaminophen's central analgesic activity.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
BENZHYDROCODONE TARGET BENZHYDROCODONE marketed Opioid analgesic combination; full mu-opioid agonist with non-opioid analgesic Mu-opioid receptors (primary); delta and kappa opioid receptors (secondary); central nervous system pain pathways 2018-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Opioid analgesic combination; full mu-opioid agonist with non-opioid analgesic class)

  1. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). BENZHYDROCODONE — Competitive Intelligence Brief. https://druglandscape.com/ci/benzhydrocodone. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators: